BBH vs IBB: which is really different?

BBH and IBB hold 64% of their weight in the same names, and BBH returned +38.3% over the year. VanEck Biotech ETF and iShares Biotechnology ETF.

BBH costs 0.09 points a year less; their one-year returns differ by 2.2 points; IBB is far larger, $10.8bn against $472m.

BBHIBB
Expense ratio0.35%0.44%
Net assets, BBH as of Oct 8, 2026 and IBB as of Oct 9, 2026$472m$10.8bn
Total return, 1 year+38.3%+36.1%
What it tracksBiotechBiotech
Holdings in common64%
S&P 500, total return, 1 year+17.3%
Against the S&P 500, 1 yearahead by 21.1 ptsahead by 18.8 pts

Holdings in common uses holdings dated Oct 8, 2026.

61.3%
BBH in the S&P 500
39.5%
IBB in the S&P 500
+38.3%
BBH total return, 1 year
+36.1%
IBB total return, 1 year
BBH · 1 year to Oct 9, 202639% of its weight is outside the S&P 500
39% of its weight is outside the S&P 50061% of BBH's weight is in S&P 500 companies and 39% is outside the index. Holdings as of Oct 8, 2026.61%39%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 73% of the fund · 25 holdings as published by its issuer for Oct 8, 2026 · Nasdaq-100: 49% in39% of its weight is outside the S&P 50061% of BBH's weight is in S&P 500 companies and 39% is outside the index. Holdings as of Oct 8, 2026.61%39%in the S&P 500outsideactive share 99% · Nasdaq-100: 49% in

61% of BBH's weight is in S&P 500 companies and 39% is outside the index. Holdings as of Oct 8, 2026.

IBB · 1 year to Oct 9, 202661% of its weight is outside the S&P 500
61% of its weight is outside the S&P 50040% of IBB's weight is in S&P 500 companies and 61% is outside the index. Holdings as of Oct 8, 2026.40%61%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 50% of the fund · 245 holdings as published by its issuer for Oct 8, 2026 · Nasdaq-100: 33% in61% of its weight is outside the S&P 50040% of IBB's weight is in S&P 500 companies and 61% is outside the index. Holdings as of Oct 8, 2026.40%61%in the S&P 500outside the S&P 500active share 99% · Nasdaq-100: 33% in

40% of IBB's weight is in S&P 500 companies and 61% is outside the index. Holdings as of Oct 8, 2026.

ETFIQ Off-Index Score · BBH and IBB score the sameHow much of it is not the index it is sold as an alternative to?
0.1, the lowest in this set92.3, the highest

A percentile among the 391 thematic ETFs with a holdings filing. All thematic ETFs ranked by it → How it is computed →

What they hold in common

By the books each fund has filed, BBH and IBB hold 64% of their money in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice. Holdings dated Oct 8, 2026.

half

64% in common

Positions both hold, largest shared weight first
Holding BBH IBB
Gilead Sciences Inc 13.58% 8.37%
Amgen Inc 15.92% 7.89%
Vertex Pharmaceuticals Inc 8.26% 7.69%
Regeneron Pharmaceuticals Inc 6.62% 5.40%
Moderna Inc 6.47% 5.30%
Natera Inc 5.27% 3.88%
Argenx Se 4.09% 3.35%
Illumina Inc 4.08% 2.94%
Revolution Medicines Inc 4.04% 2.67%
Biogen Inc 2.76% 2.36%
Alnylam Pharmaceuticals Inc 2.56% 2.21%
Beone Medicines Ltd 2.75% 2.17%
Only in BBH
Iqvia Holdings Inc 4.49%
Guardant Health Inc 2.91%
Icon Plc 1.26%
Qiagen Nv 0.98%
Only in IBB
GENMAB SPONSORED ADR 1.47%
ROIVANT SCIENCES LTD 1.32%
EXELIXIS INC 1.04%
ASCENDIS PHARMA 1.01%
MEDPACE HOLDINGS 1.00%
HALOZYME THERAPEUTICS 0.91%
BRIDGEBIO PHARMA 0.84%
MADRIGAL PHARMACEUTICALS 0.76%

64% of the two portfolios are the same securities at the same weight.

Performance, window by window

Total returnvs the S&P 500vs the Nasdaq-100
WindowBBHIBBBBHIBBBBHIBB
3 months+17.0%+7.5%+13.6 pts+4.1 pts+13.3 pts+3.9 pts
6 months+28.9%+21.9%+13.8 pts+6.8 pts+5.7 pts−1.3 pts
1 year+38.3%+36.1%+21.1 pts+18.8 pts+14.7 pts+12.5 pts
3 years+55.9%+69.1%−29.9 pts−16.7 pts−51.4 pts−38.2 pts
Since launch
BBH Dec 2011 · IBB Feb 2001
+617.4%+525.3%−94.0 pts−299.7 pts−807.3 pts−936.3 pts

Source: ETFIQ. Open the live comparison on ETFIQ →

On the same fields

BBH
VanEck Biotech ETF · Holds 25 stocks in biotech, 61% of its weight in S&P 500 companies
IBB
iShares Biotechnology ETF · Holds 245 stocks in biotech, 40% of its weight in S&P 500 companies
Theme Biotech Biotech
In the S&P 500 61.3% 39.5%
Active share vs the S&P 500 99.0% 99.0%
In the Nasdaq-100 48.7% 33.1%
Holdings 25 245
Top ten, share of the fund 72.8% 49.9%
Expense ratio 0.35% 0.44%
Fee for the differing part 0.35% 0.44%
Total return, 1 year +38.3% +36.1%
vs the S&P 500 +21.1 pts +18.8 pts
vs the Nasdaq-100 +14.7 pts +12.5 pts
Below its high −2.1% −4.8%
Net assets, BBH as of Oct 8, 2026 and IBB as of Oct 9, 2026 $472m $10.8bn

As of Oct 9, 2026. Source: ETFIQ.

BBH in plain words

By weight, 61% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 73% of the fund across 25 positions, as published by its issuer for Oct 8, 2026. Over the year to Oct 9, 2026 the fund returned +38.3% with distributions reinvested against +17.3% for the S&P 500, so a holder was ahead by 21.1 pts.

IBB in plain words

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 8, 2026. Over the year to Oct 9, 2026 the fund returned +36.1% with distributions reinvested against +17.3% for the S&P 500, so a holder was ahead by 18.8 pts.

Questions people ask

Do BBH and IBB hold the same stocks?
By their latest filings, 64% of their books are the same securities at the same weight, which is close to holding one of them twice. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBH or IBB?
BBH has 61% of its weight in S&P 500 names and IBB has 40%, so BBH differs more from the index.
Which is cheaper, BBH or IBB?
BBH charges 0.35% a year and IBB charges 0.44%, so BBH is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from

ETFIQ links to the documents behind every figure; a link is not an endorsement. A comparison is not a recommendation.

How this is computed

It is a position in a set, not a rating, and neither end of it is a recommendation.

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed.

Every figure is an ETFIQ calculation with distributions reinvested.

Cite this page

ETFIQ, BBH against IBB, data as of Oct 9, 2026. https://etfiq.com/compare/themes/bbh-vs-ibb

Open data

Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms.